Peking Union Medical College Hospital: Thrombocytopenia trials
The registry lists 10 Thrombocytopenia studies with Peking Union Medical College Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 2 7Phase 3 4Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingNCT06478537Phase 2
- CNCT19 Cell Injection for Refractory Systemic Lupus ErythematosusEnrolling by invitationNCT05930314Early Phase 1
- Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
- Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
- Hetrombopag for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT05024877Phase 2/3
- Efficacy and Safety of Avatrombopag in Cancer Patients With ThrombocytopeniaStatus unknownNCT04896528Phase 2
- Umbilical Cord Blood Treatment for Refractory Immune CytopeniaStatus unknownNCT04420494Not applicable
- A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT04324060Phase 2/3
- Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaCompletedNCT04083014Phase 2
- Study of Sirolimus in CTD-TP in ChinaStatus unknownNCT03688191Phase 4